Recent advancement in management of hemodialysis patients has increased the number of aged patients, however, major risks have encountered among them because of the diminishing reserved function of their organs by aging. Trouble in blood access is one of the major complications in these patients.
From 1976 through 1981, 12 patients, older than 75 years, with chronic renal failure were enroled to the chronic hemodialysis program at the renal center of Keio University Hospital.
In five out of the 12 patients, 14 shunt failures developed due to thrombosis, infection and aneurysm on 11, 2 and one occasions, respectively. Nine of 14 shunt failures took place in short after construction, namely within 10 times of use, including 5 before use.
The shunt failed group tended to have laboratory findings beyond normal range, either higher or lower, including platelet count, serum cholesterol and serum fibrinogen as well as mean blood pressure, although there was no significant differences in these average values comparing with those of the shunt patent group.
There were 2 patients in whom polytetrafluoroethylene (PTFE) grafts were used for blood access because of frequent shunt failures of the autogenous grafts.
Use of anticoagulants such as heparin, urokinase, warfarin and aspirin, single or combination thereof seemed effective to lessen the loss of blood access by thrombosis, especially in these two patients.
Our proposal is to use anticoagulants and/or antiplatelet agents routinely in aged patients maintained with chronic hemodialysis.
View full abstract